Jubilant Therapeutics and OneThree Biotech Collaborate to Advance Precision Oncology

Corporate Breaking News

Home : Jubilant Therapeutics and OneThree Biotech Collaborate to Advance Precision Oncology

Nov 12 2020	Jubilant Therapeutics and OneThree Biotech Collaborate to Advance Precision Oncology
BEDMINSTER, N.J. and NEW YORK, Nov. 12, 2020 /PRNewswire/ -- Jubilant Therapeutics Inc. ('Jubilant'), a biopharmaceutical company advancing small molecule modulators to address unmet medical needs in oncology and autoimmune diseases, and OneThree Biotech, a company redesigning drug...


Source:https://www.prnewswire.com:443/news-releases/jubilant-therapeutics-and-onethree-biotech-collaborate-to-advance-precision-oncology-301171578.html

Related News
» HRMA-LLC Announces New Partnership With Travel Merchant Payment Solution » Electric Toothbrush Market Revenue Worth $4.8 Billion by 2030: P&S Intelligence